Pulse Biosciences (NASDAQ:PLSE – Get Free Report) is scheduled to be issuing its quarterly earnings data after the market closes on Tuesday, May 7th. Individual that are interested in participating in the company’s earnings conference call can do so using this link.
Pulse Biosciences (NASDAQ:PLSE – Get Free Report) last posted its quarterly earnings data on Thursday, March 28th. The company reported ($0.21) EPS for the quarter.
Pulse Biosciences Price Performance
Shares of Pulse Biosciences stock traded up $0.19 during midday trading on Tuesday, reaching $7.44. The company had a trading volume of 27,953 shares, compared to its average volume of 177,623. The stock has a fifty day moving average price of $8.66 and a 200 day moving average price of $8.25. The firm has a market cap of $410.84 million, a PE ratio of -8.15 and a beta of 1.67. Pulse Biosciences has a fifty-two week low of $3.78 and a fifty-two week high of $13.62.
Pulse Biosciences Company Profile
Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.
Featured Articles
- Five stocks we like better than Pulse Biosciences
- Using the MarketBeat Dividend Yield Calculator
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Energy and Oil Stocks Explained
- Hilton Demonstrates Asset Light is Right for Investors
- How Technical Indicators Can Help You Find Oversold Stocks
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Pulse Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulse Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
